globe usa magnifying-glass checkbox g-plus rss youtube fb-round connect-with-us-in connect-with-us-twitter youtube2 facebook linkedin twitter
The website you have requested may contain information on products or uses of such products that are not approved in your country. For specific product and country information please contact Medinol


  • 0.04mm in-stent late-loss at 6 months
  • 3.4% target lesion failure at 12 months
  • EluNIR was found non-inferior to Resolute Integrity in a broad, less selected ‘more comers’ population
In Stent Late-Loss at 6 Months (mm)

TLF/MACE at 12 Months

Watch Dr. David Kandzari as he reviews the EluNIR clinical program